Metachromatic Leukodystrophy in Pakistan
How patients in Pakistan access treatment for metachromatic leukodystrophy via Named Patient Program.
About Metachromatic Leukodystrophy
Neurology
Treatment access in Pakistan
Pakistan's DRAP permits personal-use import of unregistered specialty drugs; documentation-heavy process.
For patients in Pakistan with metachromatic leukodystrophy whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with metachromatic leukodystrophy in Pakistan
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in Pakistan and confirm US supply.
- Treating physician in Pakistan issues prescription and justification.
- We file Pakistan-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Pakistan.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.